9/13/2025NHSA Issues the Regulations on DRG/DIP Healthcare Security Payment Mec...

9/12/2025The Rise of US-China Biotech Partnerships: Opportunities and Emerging ...

9/12/2025CDE Solicits Comments on Draft Guidance for Insomnia Drug Clinical Tri...

9/11/2025Chinese Biotechs Face Rising Hurdles in Advanced Therapies

9/11/2025Novartis Gains Expanded Approval for Tabrecta in China

9/11/2025RabPharma Raises Oversubscribed Series A++ to Push Ahead with RAB001d ...

9/10/2025Trump Admin Weighs Tighter Curbs on U.S. Licensing of China-Originated...

9/10/2025U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on Chi...

9/9/2025BioNTech and BMS Report Promising Global Phase II Data for Pumitamig

9/9/2025RemeGen's Telitacicept Advances in Sjögren's Syndrome

9/9/2025China's PD-(L)1 Market Shows Continued Growth in H1 2025, Domestic Bra...

9/8/2025Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...

9/8/2025Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...

9/8/2025NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...

9/8/2025NHSA Seeks Feedback on Draft Implementation Rules for Medical Insuranc...

9/5/2025BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...

9/5/2025How China Seeks to Solve Its Quality Control Conundrum (C&EN)

9/4/2025Baili-Bio Launches Phase 3 Trial for HER2-Targeted ADC in Gastric Canc...

9/3/2025Global Pharma Firms Pour $48 Billion into China in H1 2025, IQVIA Repo...

9/3/2025Sanofi China Receives Approval for Tzield to Delay Progression of Type...

9/3/2025China to Become World's Third-Largest Innovative Drug Market by 2028:...

9/3/2025Aon Report Highlights Rapid Growth and Challenges in China's Health In...

9/3/2025China's Biopharma Industry Clusters: Mapping Opportunities and Regiona...

9/3/2025China Biopharma Tracker – August 2025 (PharmaDJ)

9/2/2025Novatim and Radiance Forge Global Licensing Deal for Novel Cancer Ther...

9/2/2025Astellas Accelerates Growth and Innovation in China

8/30/2025CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib

8/30/2025Recent Executive Moves

8/29/2025NHSA Announces Results of Form Review for 2025 NRDL Submissions

8/29/2025CDE Solicits Comments on Draft Guideline for Post-Approval Change Mana...

Page:1/367 Total number of articles:10986: [First][<<] [1] [2] [3] [4] [5] [>>] [End]